−0.44USD
−13.07 MUSD
17.03 M
About Telomir Pharmaceuticals, Inc.
Sector
CEO
Christopher C. Chapman
Headquarters
Baltimore
Website
Employees (FY)
9
Founded
2021
ISIN
US87975F1049
FIGI
BBG01K4SG3V0
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. It focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm’s initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ. TELOMIR-1 is under investigation to provide a potential therapeutic intervention against age-related inflammatory conditions such as hemochromatosis, as well as for post-chemotherapy recovery, by interrupting and preventing the IL-17 induced inflammatory pathways that create the systemic imbalance of cellular metals. The company was founded on August 26, 2021 and is headquartered in Baltimore, MD.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TELO is 7.99 USD — it has increased by 0.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Telomir Pharmaceuticals, Inc. stocks are traded under the ticker TELO.
TELO stock is 9.01% volatile and has beta coefficient of −8.48. Check out the list of the most volatile stocks — is Telomir Pharmaceuticals, Inc. there?
Yes, you can track Telomir Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
TELO stock has fallen by 7.15% compared to the previous week, the month change is a 32.42% rise, over the last year Telomir Pharmaceuticals, Inc. has showed a 14.07% increase.
TELO net income for the last quarter is −9.33 M USD, while the quarter before that showed −1.71 M USD of net income which accounts for −445.03% change. Track more Telomir Pharmaceuticals, Inc. financial stats to get the full picture.
No, TELO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TELO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Telomir Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 9.00 employees. See our rating of the largest employees — is Telomir Pharmaceuticals, Inc. on this list?